Related Experiment Video
Updated: Mar 7, 2026

Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
Protection against Shiga Toxins
Simona Kavaliauskiene1,2, Anne Berit Dyve Lingelem3,4, Tore Skotland5,6
1Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, N-0379 Oslo, Norway. simona.kavaliauskiene@rr-research.no.
Abstract:
Shiga toxins consist of an A-moiety and five B-moieties able to bind the neutral glycosphingolipid globotriaosylceramide (Gb3) on the cell surface. To intoxicate cells efficiently, the toxin A-moiety has to be cleaved by furin and transported retrogradely to the Golgi apparatus and to the endoplasmic reticulum. The enzymatically active part of the A-moiety is then translocated to the cytosol, where it inhibits protein synthesis and in some cell types induces apoptosis. Protection of cells can be provided either by inhibiting binding of the toxin to cells or by interfering with any of the subsequent steps required for its toxic effect. In this article we provide a brief overview of the interaction of Shiga toxins with cells, describe some compounds and conditions found to protect cells against Shiga toxins, and discuss whether they might also provide protection in animals and humans.
Insights
Shiga toxins enter cells via globotriaosylceramide (Gb3) binding and internal processing to inhibit protein synthesis. Researchers reviewed compounds and conditions that protect cells from Shiga toxin effects, exploring potential human and animal applications.
Area of Science:
- Microbiology
- Cell Biology
- Toxicology
Background:
- Shiga toxins (STs) are potent protein toxins produced by bacteria like E. coli and Shigella.
- STs bind to globotriaosylceramide (Gb3) on host cell surfaces via their B-subunit.
- Cellular intoxication involves retrograde transport of the A-subunit to the cytosol, inhibiting protein synthesis and inducing apoptosis.
Purpose of the Study:
- To provide an overview of Shiga toxin-cell interactions.
- To describe compounds and conditions that confer cellular protection against STs.
- To discuss the potential translational application of these protective strategies in humans and animals.
Main Methods:
- Literature review of studies on Shiga toxin mechanisms.
- Analysis of reported cellular protection strategies against STs.
- Evaluation of evidence for in vivo efficacy of protective measures.
Main Results:
- Cellular protection can be achieved by blocking Gb3 binding or interfering with intracellular toxin trafficking and activity.
- Various compounds and conditions have demonstrated protective effects in vitro.
- The translation of these findings to effective in vivo therapies requires further investigation.
Conclusions:
- Understanding Shiga toxin cell entry and intracellular mechanisms is crucial for developing countermeasures.
- Targeting toxin binding or intracellular pathways offers potential therapeutic avenues.
- Further research is needed to validate protective strategies for clinical use in preventing Shiga toxin-induced diseases.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Stringent Response in E. coli
Endospores and Sporulation
Other Stress Responses in Bacteria
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...

